APA (7th ed.) Citation

Cortes, J. E., Kim, D., Pinilla-Ibarz, J., le Coutre, P. D., Paquette, R., Chuah, C., . . . Kantarjian, H. M. (2018). Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: Final 5-year results of the phase 2 PACE trial. Blood, 132(4), 393-404. https://doi.org/10.1182/blood-2016-09-739086

Chicago Style (17th ed.) Citation

Cortes, Jorge E., et al. "Ponatinib Efficacy and Safety in Philadelphia Chromosome–positive Leukemia: Final 5-year Results of the Phase 2 PACE Trial." Blood 132, no. 4 (2018): 393-404. https://doi.org/10.1182/blood-2016-09-739086.

MLA (9th ed.) Citation

Cortes, Jorge E., et al. "Ponatinib Efficacy and Safety in Philadelphia Chromosome–positive Leukemia: Final 5-year Results of the Phase 2 PACE Trial." Blood, vol. 132, no. 4, 2018, pp. 393-404, https://doi.org/10.1182/blood-2016-09-739086.